1. Phase I, dose-escalation, clinical trial of MVA-Brachyury-TRICOM vaccine demonstrating safety and brachyury-specific T cell responses. Issue 2 (December 2015) Authors: Heery, Christopher; Donahue, Renee; Lepone, Lauren; Grenga, Italia; Richards, Jacob; Metenou, Simon; Fernando, Romaine; Dirmeier, Ulrike; Singh, Harpreet; Madan, Ravi; Gulley, James; Schlom, Jeffrey Journal: Journal for immunotherapy of cancer Issue: Volume 3:Issue 2(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. The generation and analysis of a novel combination of recombinant adenovirus vaccines targeting three tumor antigens as an immunotherapeutic. Issue 2 (December 2015) Authors: Tsang, Kwong; Gabitzsch, Elizabeth; Palena, Claudia; David, Justin; Fantini, Massimo; Kwilas, Anna; Rice, Adrian; Latchman, Yvette; Hodge, James; Jochems, Caroline; Fernando, Romaine; Gulley, James; Madan, Ravi; Heery, Christopher; Balint, Joseph; Jones, Frank; Schlom, Jeffrey Journal: Journal for immunotherapy of cancer Issue: Volume 3:Issue 2(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Treatment with the IDO inhibitor INCB024360 increased lysis of human tumor cell targets by peptide-specific CTL. Issue 2 (December 2015) Authors: Jochems, Caroline; Kwilas, Anna; Kim, Young-Seung; Brechbiel, Martin; Fantini, Massimo; Metenou, Simon; Fernando, Romaine; Kim, Peter; Gameiro, Sofia; Hodge, James; Newton, Robert; Schlom, Jeffrey; Tsang, Kwong Journal: Journal for immunotherapy of cancer Issue: Volume 3:Issue 2(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗